INS and type 2 diabetes mellitus: In T2DM, skeletal muscle dysfunction is characterized by elevated levels of circulating free fatty acids (FFAs), which impair fat oxidation and promote lipid accumulation in muscle cells and lead to reduced insulin-stimulated glucose uptake (Phielix and Mensink, 2008).